IDG Capital, CDH Investments Lead $44M Series B Round In Chinese Biotech Start-Up

Login to View

Creative Biosciences, a Chinese biotechnology start-up focusing on colorectal cancer detection, announced on Friday the completion of a RMB300 million (US$44.64 million) series B round of financing led by Boston-born investment firm IDG Capital and Chinese private equity firm CDH Investments.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in